Miller LJ, Chen Q, Lam PC-H, Pinon DI, Sexton PM, et al
Advantage : Neither (tie) Summary and Verdict# CagriSema and tirzepatide achieve remarkably similar weight loss (20.4% vs 20.9%) through fundamentally different dual mechanisms -- amylin/GLP-1 versus GIP/GLP-1
Mindful eating becomes easier : With GLP-1 regulating hunger cues, pairing meals with intention and awareness feels more natural
The protein trend has also given way to innovation beyond sheer volume
That said, review patterns consistently point to reliability of dispatch - rather than headline promises - as the better indicator of what to expect
These medications are often prescribed alongside lifestyle changes like diet and exercise, especially for people with obesity or prediabetes who havent had success with weight loss on their own